EditorialsALMs versus DALMs in ulcerative colitis: Polypectomy or colectomy?☆
References (20)
- et al.
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications
Hum Pathol
(1983) - et al.
Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis
Gastroenterology
(1994) - et al.
Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study
Gastroenterology
(1998) - et al.
The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis
Am J Gastroenterol
(1999) - et al.
Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis
Gastroenterology
(1999) - et al.
Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps
Gastroenterology
(1999) - et al.
Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy
Gastroenterology
(1981) - et al.
Cancer surveillance in ulcerative colitis
Gastroenterology
(1991) - et al.
Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis
Gastroenterology
(1997) The case against dysplasia surveillance in ulcerative colitis
There are more references available in the full text version of this article.
Cited by (0)
- ☆
Address requests for reprints to: Charles N. Bernstein, M.D., University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, GB-443 Health Sciences Centre, Winnipeg, Manitoba, Canada R3A-1R9. Fax: (204) 787-4826.
Copyright © 1999 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.